Textured Breast Implants Recalled By Allergan Due To Lymphoma Risk
(July 24, 2019, 1:43 PM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on July 24 asked Allergan PLC to recall its Biocell textured breast implants due to the increased risk of anaplastic large cell...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login